133992-66-2Relevant articles and documents
Dabigatran etexilate derivative and pharmaceutical use thereof
-
Paragraph 0313; 0316-0318, (2019/07/04)
The invention discloses a compound shown as formula (II), a hydrate, isomer, solvate, prodrug or a mixture thereof, and pharmaceutically acceptable salts thereof. The invention also discloses a pharmaceutical composition and a combination preparation containing the compounds as active ingredients, and use of the compounds, the pharmaceutical composition and the combination preparation as thrombininhibitors.